Metagenomi Therapeutics, Inc. MGX
NASDAQ · United States · Health Technology
$1.08+0.01 (+1.42%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.73 | -0.55 | -32.0% | -$257.00K | -108.5% | -1.6%$1.23→$1.21 |
| Q1 2026 | 2026-05-11 | -0.61 | -0.60 | -1.7% | — | — | -4.3%$1.41→$1.35 |
| Q4 2025 | 2026-03-05 | -0.60 | -0.61 | +1.6% | — | — | -7.5%$1.60→$1.48 |
| Q3 2025 | 2025-11-11 | -0.55 | -0.53 | -3.8% | — | — | -13.5%$2.15→$1.86 |
| Q4 2024 | 2025-03-17 | -0.63 | -0.78 | +19.2% | — | — | — |
| Q4 2023 | 2024-03-27 | -9.91 | -1.66 | -497.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.